Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Inspira Technologies Oxy BHN ( (IINN) ) just unveiled an update.
On October 21, 2025, Inspira Technologies Oxy B.H.N. Ltd. announced significant leadership changes to enhance its global commercialization and governance. The company appointed Mike Hershkovitz as Vice President of Global Sales and Sivan Matza as an independent director on the board. Hershkovitz, with extensive experience in the healthcare market, will lead sales strategies, while Matza’s expertise in global finance will strengthen governance as the company expands. These appointments are expected to drive Inspira’s growth and operational execution, aligning with industry trends of consolidation and strategic partnerships.
The most recent analyst rating on (IINN) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Inspira Technologies Oxy BHN stock, see the IINN Stock Forecast page.
Spark’s Take on IINN Stock
According to Spark, TipRanks’ AI Analyst, IINN is a Underperform.
The overall stock score reflects significant financial instability, as indicated by ongoing losses and reliance on external funding. The technical analysis shows bearish sentiment, with the stock under pressure. Valuation is challenging due to negative earnings and lack of dividend yield, making the stock less appealing to investors.
To see Spark’s full report on IINN stock, click here.
More about Inspira Technologies Oxy BHN
Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions. The company offers the INSPIRA ART100 system, approved for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S., and is developing the INSPIRA ART500. Inspira Technologies is also advancing HYLA, a proprietary blood sensor platform, positioning itself as a key player in the life-support and MedTech landscape.
Average Trading Volume: 681,823
Technical Sentiment Signal: Buy
Current Market Cap: $28.95M
For an in-depth examination of IINN stock, go to TipRanks’ Overview page.